In particular, TAAR1 activation has been reported to reduce fasting glucose levels, delay gastric emptying, enhance satiety, and suppress food intake, effects that highlight its therapeutic relevance for obesity management [2]. The gene discussed is TAAR1; the disease is obesity disorder.